Warning letter
Majopa Industries Corporation: warning letter of Jan 20, 2016
FDA warning letter 478189 · San Juan District Office
Key facts
| Reference number | 478189 |
|---|---|
| Company | Majopa Industries Corporation |
| Subject | CGMP/Dietary Supplement/Adulterated |
| Issue date | Jan 20, 2016 |
| Posted date | Feb 16, 2016 |
| Issuing office | San Juan District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.36, 111, 111.103, 111.210, 111.553, 111.70(b), 111.70(d), 111.70(e), 111.205(a), 111.210(h), 111.210(h)(2), 111.255(a) and 4 more |
| Inspection city | Guayama |
| Inspection ZIP | 00784 |
| Inspection start date | Jul 30, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: